Overview

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

The study is a prospective, randomised, controlled, and non-blinded multi-center pilot study to evaluate endocrine efficacy of recombinant luteinizing hormone versus recombinant human chorionic gonadotropin administered during controlled ovarian stimulation for IVF/ICSI in normogonadotrophic women.

Phase:

Phase 4

Details

Lead Sponsor:

Regionshospitalet Viborg, Skive

Treatments:

Chorionic Gonadotropin
Follicle Stimulating Hormone
Hormones